Literature DB >> 1586607

Surveillance following orchidectomy for stage I testicular seminoma.

A Horwich1, N Alsanjari, R A'Hern, J Nicholls, D P Dearnaley, C Fisher.   

Abstract

An analysis of the primary tumour histopathology was performed on 103 patients managed by orchidectomy and surveillance for stage I seminoma. Patients have been followed for 14-141 months (median 62 months) after orchidectomy. Seventeen patients relapsed, the probability of remaining relapse free at 5 years being 82% (95% confidence intervals, 74%-88%). No patients died of progressive germ cell tumours. The only significant histological factor predicting relapse was the presence of lymphatic and vascular invasion. Four of 42 patients with neither lymphatic or vascular invasion recurred, nine of 53 patients with either lymphatic or vascular invasion recurred and three of eight cases with both lymphatic and vascular invasion recurred (P = 0.05-trend). Though initial recurrence was usually of moderate volume and confined to para-aortic nodes, eight patients were treated with chemotherapy either because of the extent of their initial relapse (four cases), or because of subsequent relapse (four cases). In view of the difficulties of identifying patients at risk and of detecting early relapse, surveillance for stage I seminoma should remain a research protocol.

Entities:  

Mesh:

Year:  1992        PMID: 1586607      PMCID: PMC1977398          DOI: 10.1038/bjc.1992.164

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Seminoma of the testis: analysis of treatment success and failure.

Authors:  J G Maier; M H Sulak; B T Mittemeyer
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-03

2.  Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone.

Authors:  L S Freedman; M C Parkinson; W G Jones; R T Oliver; M J Peckham; G Read; E S Newlands; C J Williams
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

3.  Inguinal and iliac lymph node involvement in germ cell tumours of the testis: implications for radiological investigation and for therapy.

Authors:  M D Mason; T Featherstone; J Olliff; A Horwich
Journal:  Clin Oncol (R Coll Radiol)       Date:  1991-05       Impact factor: 4.126

Review 4.  Simple nontoxic treatment of advanced metastatic seminoma with carboplatin.

Authors:  A Horwich; D P Dearnaley; G M Duchesne; M Williams; M Brada; M J Peckham
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

5.  Subsequent malignancies in patients irradiated for testicular tumours.

Authors:  J H Hay; W Duncan; G R Kerr
Journal:  Br J Radiol       Date:  1984-07       Impact factor: 3.039

6.  Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis.

Authors:  C R Hamilton; A Horwich; J M Bliss; M J Peckham
Journal:  Radiother Oncol       Date:  1987-10       Impact factor: 6.280

7.  Orchidectomy alone for stage I seminoma of the testis.

Authors:  G M Duchesne; A Horwich; D P Dearnaley; J Nicholls; G Jay; M J Peckham; W F Hendry
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

8.  A study of post-orchiectomy surveillance in stage I testicular seminoma.

Authors:  G M Thomas; J F Sturgeon; R Alison; M Jewett; S Goldberg; L Sugar; D Rideout; M K Gospodarowicz; W Duncan
Journal:  J Urol       Date:  1989-08       Impact factor: 7.450

9.  Mortality among patients with ankylosing spondylitis after a single treatment course with x rays.

Authors:  P G Smith; R Doll
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-13

10.  Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.

Authors:  S D Fosså; F Langmark; N Aass; A Andersen; R Lothe; A L Børresen
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

View more
  21 in total

1.  Canadian consensus guidelines for the management of testicular germ cell cancer.

Authors:  Lori Wood; Christian Kollmannsberger; Michael Jewett; Peter Chung; Sebastian Hotte; Martin O'Malley; Joan Sweet; Lynn Anson-Cartwright; Eric Winquist; Scott North; Scott Tyldesley; Jeremy Sturgeon; Mary Gospodarowicz; Roanne Segal; Tina Cheng; Peter Venner; Malcolm Moore; Peter Albers; Robert Huddart; Craig Nichols; Padraig Warde
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

Review 2.  Controversies in the management of early-stage germ cell tumors.

Authors:  Ann Tan; Timothy Gilligan
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

Review 3.  [Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors].

Authors:  S Machtens; A R Boerner; M Hofmann; W H Knapp; U Jonas
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

Review 4.  [Therapeutical options for seminomas at clinical stage I-IIA/B].

Authors:  A Heidenreich
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

Review 5.  Clinical stage I seminoma: the case for surveillance.

Authors:  Nathan Lawrentschuk; Neil Fleshner
Journal:  World J Urol       Date:  2009-06-11       Impact factor: 4.226

6.  Update on management of seminoma.

Authors:  Emma J Alexander; Ingrid M White; Alan Horwich
Journal:  Indian J Urol       Date:  2010 Jan-Mar

7.  Fusion imaging: a novel staging modality in testis cancer.

Authors:  Joseph R Sterbis; Kevin R Rice; Marcia C Javitt; Noah S Schenkman; Stephen A Brassell
Journal:  J Cancer       Date:  2010-11-05       Impact factor: 4.207

8.  Current treatment options for clinical stage I seminoma.

Authors:  Andrew J Stephenson
Journal:  World J Urol       Date:  2009-04-16       Impact factor: 4.226

9.  Adjuvant carboplatin treatment for seminoma clinical stage I.

Authors:  K P Dieckmann; J Krain; J Küster; B Brüggeboes
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 10.  Positron emission tomography (PET) in the urooncological evaluation of the small pelvis.

Authors:  S Machtens; J Serth; A Meyer; C Kleinhorst; K-J Ommer; U Herbst; M Kieruij; A R Boerner
Journal:  World J Urol       Date:  2007-07-12       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.